Encyclopedia of Signaling Molecules

2012 Edition
| Editors: Sangdun Choi

RGS13

Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-0461-4_261

Synonyms

Historical Background

Regulator of G-protein signaling (RGS) is a protein superfamily discovered in the mid-1990s (Druey et al. 1996; Watson et al. 1996; Hunt et al. 1996). Since that time more than 30 members in the family have been identified. The major physiological function of RGS molecules is to negatively modulate G-protein coupled receptor (GPCR)-mediated signaling and biology (Bansal et al. 2007; Neitzel and Hepler 2006; Thompson et al. 2008).  RGS13 was first identified in 1996 and is one of the smallest molecules in the family (Druey et al. 1996). Full length human RGS13 cDNA was cloned and deposited into gene bank in 1997 by Chatterjee and Fisher. In 2002, the first functional studies of human RGS13 were reported. RGS13 was shown to inhibit muscarinic M1- and M2 receptor-induced  MAP kinase activation (Johnson and Druey 2002). Concurrently, a separate study characterized mouse RGS13, which was cloned from B cells. RGS13...

This is a preview of subscription content, log in to check access

Notes

Acknowledgments

This study was supported by the Intramural Research Program of the NIH, NIAID.

References

  1. Bansal G, Druey KM, Xie Z. Pharmacol Ther. 2007;116:473–95.PubMedCrossRefGoogle Scholar
  2. Bansal G, Xie Z, Rao S, Nocka KH, Druey KM. Nat Immunol. 2008a;9:73–80.PubMedCrossRefGoogle Scholar
  3. Bansal G, DiVietro JA, Kuehn HS, Rao S, Nocka KH, Gilfillan AM, Druey KM. J Immunol. 2008b;181:7882–90.PubMedGoogle Scholar
  4. Druey KM, Blumer KJ, Kang VH, Kehrl JH. Nature. 1996;379:742–6.PubMedCrossRefGoogle Scholar
  5. Gilfillan AM, Tkaczyk C. Nat Rev Immunol. 2006;6:218–30.PubMedCrossRefGoogle Scholar
  6. Grafstein-Dunn E, Young KH, Cockett MI, Khawaja XZ. Brain Res Mol Brain Res. 2001;88:113–23.PubMedCrossRefGoogle Scholar
  7. Han JI, Huang NN, Kim DU, Kehrl JH. J Leukoc Biol. 2006;79:1357–68.PubMedCrossRefGoogle Scholar
  8. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD. Nat Immunol. 2008;9:166–75.PubMedCrossRefGoogle Scholar
  9. Hunt TW, Fields TA, Casey PJ, Peralta EG. Nature. 1996;383:175–7.PubMedCrossRefGoogle Scholar
  10. Islam TC, Asplund AC, Lindvall JM, Nygren L, Liden J, Kimby E, Christensson B, Smith CI, Sander B. Leukemia. 2003;17:1880–90.PubMedCrossRefGoogle Scholar
  11. Iwaki S, Lu Y, Xie Z, Druey KM. J Biol Chem. 2011; epublished ahead of print.Google Scholar
  12. Johnson EN, Druey KM. J Biol Chem. 2002;277:16768–74.PubMedCrossRefGoogle Scholar
  13. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. Brain Res Mol Brain Res. 2004;122:24–34.PubMedCrossRefGoogle Scholar
  14. Neitzel KL, Hepler JR. Semin Cell Dev Biol. 2006;17:383–9.PubMedCrossRefGoogle Scholar
  15. Patel TB. Pharmacol Rev. 2004;56:371–85.PubMedCrossRefGoogle Scholar
  16. Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN. Blood. 2009;113:4016–26.PubMedCrossRefGoogle Scholar
  17. Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. J Immunol. 2002;169:2507–15.PubMedGoogle Scholar
  18. Thompson MD, Cole DE, Jose PA. Methods Mol Biol. 2008;448:77–107.PubMedCrossRefGoogle Scholar
  19. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. Nature. 1996;383:172–5.PubMedCrossRefGoogle Scholar
  20. Xie Z, Geiger TR, Johnson EN, Nyborg JK, Druey KM. Mol Cell. 2008;31:660–70.PubMedCrossRefGoogle Scholar
  21. Xie Z, Yang Z, Druey KM. J Mol Cell Biol. 2010;2:357–65.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Laboratory of Allergic DiseasesNational Institute of Allergy and infectious Diseases, National Institutes of HealthBethesdaUSA